SCHEMBL5044308

SCHEMBL5044308

COCCCn1c(-c2csc(-c3ccc(OC)cc3)n2)cc(C(=O)O)c1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
HPGD P15428 2/20 0.54
KDM4E B2RXH2 3/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
MAPT P10636 2/20 0.51
LMNA P02545 1/20 0.51
CRHBP P24387 1/20 0.51
HTT P42858 1/20 0.51
CRHR2 Q13324 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
EIF4E P06730 4/20 0.44
KLKB1 P03952 1/20 0.44
POLB P06746 1/20 0.44
ATM Q13315 1/20 0.44
CDC25A P30304 1/20 0.41
CDC25B P30305 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5044535 0.94 ALDH1A1 (0.53) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL5039541 0.91 KDM4E (0.52) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL6882157 0.88 KDM4E (0.48) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL5045092 0.88 ALDH1A1 (0.54) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL5039436 0.88 ALDH1A1 (0.58) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL5047149 0.87 ALDH1A1 (0.42) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL5048647 0.87 ALDH1A1 (0.67) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL6879680 0.87 KDM4E (0.51) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL6473241 0.87 ATP4A (0.50) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL5045711 0.86 KDM4E (0.55) ALDH1A1HPGDKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-7135488-B2 Pyrrolyl-thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-14 US disclosed
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives HOFFMAN-LA ROCHE INC. 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives CNR1, CNR2, NPY1R ALDH1A1 959/4885HPGD 2000/4885KDM4E 2916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.